Drawing for QUALTRAK

USPTO serial 97380331

QUALTRAK

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
RINKER, ANTHONY MICHAEL
Law office
TMO LAW OFFICE 119

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QUALTRAK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

KENYA WILLIAMS

KENYA WILLIAMS THERMO FISHER SCIENTIFIC5823 NEWTON DRIVECARLSBAD, CA 92008United States

Goods and services

ClassDescriptionStatusFirst use
005Biopharmaceutical laboratory reagents, oligonucleotides, primers and probes, enzymes and enzyme mixes, nucleotide sets and nucleotide mixes, fluorescent dye, all the foregoing for in-vitro medical, clinical or biopharmaceutical use, reaction buffers and sample detection labels in the form of strips of adhesive paper labels for laboratory use for nucleic acid genotyping tools, nucleic acid quantification and nucleic acid amplification including polymerase chain reactions, and reverse transcription polymerase chain reactions, for gene expression, genotyping, microbial testing applications all the foregoing for in-vitro medical, clinical or biopharmaceutical use; Kits comprised of laboratory reagents, oligonucleotides, primers and probes, enzymes and enzyme mixes, nucleotide sets and nucleotide mixes, fluorescent dye, all the foregoing for in-vitro medical, clinical, and biopharmaceutical use, reaction buffers and sample detection labels in the form of strips of adhesive paper labels for laboratory use for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification including polymerase chain reaction and reverse transcription polymerase chain reactions, all the foregoing for in-vitro medical, or biopharmaceutical use.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 10, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 10, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 10, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2025EX2GSOU EXTENSION 2 GRANTED
Apr 10, 2025EXT2SOU EXTENSION 2 FILED
Apr 9, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 17, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 17, 2024EX1GSOU EXTENSION 1 GRANTED
Sep 17, 2024EXT1SOU EXTENSION 1 FILED
Sep 17, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 9, 2024EXPTEXPARTE APPEAL TERMINATED
Jan 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2024XAECEXAMINER'S AMENDMENT ENTERED
Jan 9, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 9, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Jan 9, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 30, 2023EXPIEX PARTE APPEAL-INSTITUTED
Nov 30, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 30, 2023EXAFEXPARTE APPEAL RECEIVED AT TTAB
Nov 30, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 8, 2023RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Nov 8, 2023RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Nov 8, 2023RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Oct 13, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 13, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED
Sep 2, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Sep 2, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 2, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 2, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 28, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 16, 2023ATRVATTORNEY REVIEW COMPLETED
Feb 13, 2023LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Feb 13, 2023LOPTLETTER OF PROTEST EVIDENCE FORWARDED
Feb 10, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2023DOCKASSIGNED TO EXAMINER
May 2, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance